Stock comparison
Side-by-side financials for CTKB and A. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
A is larger
Market cap data is available for the leading company in this comparison.
Market value leader
A
Latest market capitalization comparison.
Revenue leader
A
CTKB: $201.49M vs A: $6.95B.
Profit leader
A
CTKB: -$66.54M vs A: $1.30B.
Margin leader
A
CTKB: -33.0% vs A: 18.8% net margin.
| Metric | CTKB | A |
|---|---|---|
| Market cap | - | $37.95 B |
| US-listed rank | - | #404 |
| Revenue (latest FY) | $201.49M | $6.95B |
| Net income (latest FY) | -$66.54M | $1.30B |
| Net margin | -33.0% | 18.8% |
| P/E (trailing FY) | - | 29.1x |
| SEC filings | 432 | 2,339 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, Cytek Biosciences, Inc. reported $201.49M in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: Cytek Biosciences, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.